Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma.

Kahalley LS, Peterson R, Ris MD, Janzen L, Okcu MF, Grosshans DR, Ramaswamy V, Paulino AC, Hodgson D, Mahajan A, Tsang DS, Laperriere N, Whitehead WE, Dauser RC, Taylor MD, Conklin HM, Chintagumpala M, Bouffet E, Mabbott D.

J Clin Oncol. 2019 Nov 27:JCO1901706. doi: 10.1200/JCO.19.01706. [Epub ahead of print]

PMID:
31774710
2.

Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma.

Bielamowicz K, Okcu MF, Sonabend R, Paulino AC, Hilsenbeck SG, Dreyer Z, Suzawa H, Bryant R, Adesina A, Dauser R, Mahajan A, Chintagumpala M.

Pediatr Hematol Oncol. 2018 May;35(4):257-267. doi: 10.1080/08880018.2018.1471111. Epub 2018 Dec 11.

PMID:
30537887
3.

Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients.

Gross JP, Powell S, Zelko F, Hartsell W, Goldman S, Fangusaro J, Lulla RR, Smiley NP, Chang JH, Gondi V.

Neuro Oncol. 2019 Jul 11;21(7):934-943. doi: 10.1093/neuonc/noz070.

PMID:
30997512
4.

Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors.

Kahalley LS, Ris MD, Grosshans DR, Okcu MF, Paulino AC, Chintagumpala M, Moore BD, Guffey D, Minard CG, Stancel HH, Mahajan A.

J Clin Oncol. 2016 Apr 1;34(10):1043-9. doi: 10.1200/JCO.2015.62.1383. Epub 2016 Jan 25.

5.

Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.

Kahalley LS, Douglas Ris M, Mahajan A, Fatih Okcu M, Chintagumpala M, Paulino AC, Whitehead WE, Minard CG, Stancel HH, Orobio J, Xue JJ, Warren EA, Grosshans DR.

Neuro Oncol. 2019 Jun 10;21(6):809-818. doi: 10.1093/neuonc/noz041.

PMID:
30753584
6.

Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors.

Pulsifer MB, Duncanson H, Grieco J, Evans C, Tseretopoulos ID, MacDonald S, Tarbell NJ, Yock TI.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):391-398. doi: 10.1016/j.ijrobp.2018.05.069. Epub 2018 Jun 6.

PMID:
30108004
7.

Quality of life outcomes in proton and photon treated pediatric brain tumor survivors.

Yock TI, Bhat S, Szymonifka J, Yeap BY, Delahaye J, Donaldson SS, MacDonald SM, Pulsifer MB, Hill KS, DeLaney TF, Ebb D, Huang M, Tarbell NJ, Fisher PG, Kuhlthau KA.

Radiother Oncol. 2014 Oct;113(1):89-94. doi: 10.1016/j.radonc.2014.08.017. Epub 2014 Oct 7.

8.

Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.

Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ.

Lancet Oncol. 2016 Mar;17(3):287-98. doi: 10.1016/S1470-2045(15)00167-9. Epub 2016 Jan 30.

PMID:
26830377
9.

Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors.

Pulsifer MB, Sethi RV, Kuhlthau KA, MacDonald SM, Tarbell NJ, Yock TI.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):400-7. doi: 10.1016/j.ijrobp.2015.06.012. Epub 2015 Jun 14.

10.

Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.

Arvold ND, Niemierko A, Broussard GP, Adams J, Fullerton B, Loeffler JS, Shih HA.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e495-500. doi: 10.1016/j.ijrobp.2011.10.056. Epub 2012 Jan 26.

PMID:
22285662
11.

A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer.

Routman DM, Garant A, Lester SC, Day CN, Harmsen WS, Sanheuza CT, Yoon HH, Neben-Wittich MA, Martenson JA, Haddock MG, Hallemeier CL, Merrell KW.

Adv Radiat Oncol. 2019 Jan 17;4(1):63-69. doi: 10.1016/j.adro.2018.09.004. eCollection 2019 Jan-Mar.

12.

Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.

Moxon-Emre I, Bouffet E, Taylor MD, Laperriere N, Scantlebury N, Law N, Spiegler BJ, Malkin D, Janzen L, Mabbott D.

J Clin Oncol. 2014 Jun 10;32(17):1760-8. doi: 10.1200/JCO.2013.52.3290. Epub 2014 Feb 10.

PMID:
24516024
13.

Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.

Merchant TE, Schreiber JE, Wu S, Lukose R, Xiong X, Gajjar A.

Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):554-61. doi: 10.1016/j.ijrobp.2014.06.058. Epub 2014 Aug 23.

14.

Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.

Eaton BR, Esiashvili N, Kim S, Patterson B, Weyman EA, Thornton LT, Mazewski C, MacDonald TJ, Ebb D, MacDonald SM, Tarbell NJ, Yock TI.

Neuro Oncol. 2016 Jun;18(6):881-7. doi: 10.1093/neuonc/nov302. Epub 2015 Dec 19.

15.

Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy.

Kramer K, Pandit-Taskar N, Zanzonico P, Wolden SL, Humm JL, DeSelm C, Souweidane MM, Lewis JS, Cheung NK.

J Neurooncol. 2015 Jun;123(2):245-9. doi: 10.1007/s11060-015-1788-z. Epub 2015 May 6.

16.

Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy.

Ventura LM, Grieco JA, Evans CL, Kuhlthau KA, MacDonald SM, Tarbell NJ, Yock TI, Pulsifer MB.

J Neurooncol. 2018 Mar;137(1):119-126. doi: 10.1007/s11060-017-2703-6. Epub 2017 Dec 6.

PMID:
29214403
17.

A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer.

Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon S, Merrell KW, Haddock MG, Hallemeier CL.

Pract Radiat Oncol. 2019 Nov;9(6):410-417. doi: 10.1016/j.prro.2019.07.003. Epub 2019 Jul 13.

PMID:
31310815
18.

Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961.

Ris MD, Walsh K, Wallace D, Armstrong FD, Holmes E, Gajjar A, Zhou T, Packer RJ.

Pediatr Blood Cancer. 2013 Aug;60(8):1350-7. doi: 10.1002/pbc.24496. Epub 2013 Feb 26.

19.

Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

Palmer SL, Goloubeva O, Reddick WE, Glass JO, Gajjar A, Kun L, Merchant TE, Mulhern RK.

J Clin Oncol. 2001 Apr 15;19(8):2302-8.

PMID:
11304784
20.

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.

Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM.

J Clin Oncol. 2001 Aug 1;19(15):3470-6.

PMID:
11481352

Supplemental Content

Support Center